HF
CLB icon

Hoxton Financial’s Core Laboratories CLB Stock Holding History

Hoxton Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-508
Closed -$97K – 375
2013
Q4 		$97K Buy
508
+171
+51% +$31.8K 0.04% 151
2013
Q3 		$57K Sell
337
-62
-16% -$9.62K 0.06% 107
2013
Q2 		$61K Buy
+399
New +$56.5K 0.03% 171

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Hoxton Financial's CLB Position: Q1 2014 in Review

Hoxton Financial sold out of Core Laboratories (CLB) in Q1 2014, closing a stake of 508 shares — an estimated $97K sold.

Hoxton Financial first reported a position in CLB in Q2 2013 and held it in 3 quarters. The position peaked at $97K in Q4 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q1 2014.

  • Hoxton Financial reported no remaining Core Laboratories position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 508 Core Laboratories shares in Q1 2014, an estimated $97K.
  • Hoxton Financial first reported a position in Core Laboratories in Q2 2013 and held it in 3 quarters.
  • Hoxton Financial's Core Laboratories position peaked at $97K in Q4 2013.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.